Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Hangzhou Ruidi Biotechnology, Ltd.

Approvalsdevice cleared12 Aug 2026

Hangzhou Ruidi Biotechnology, Ltd.

12 Aug 2026: Device cleared · Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02); Disposable Sterile Steep Pulse Probe (NPA-DJ01); Probe connection line (NPA-LX-02). Recorded in the openFDA device 510(k) data.

View the source record

Decided
12 Aug 2026
Device
Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02); Disposable Sterile Steep Pulse Probe (NPA-DJ01); Probe connection line (NPA-LX-02)
Specialty
General, Plastic Surgery
Country
China
Location
Hangzhou
Clearance type
Traditional
510(k) number
K253846
Submitted
2025-12-02
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Hangzhou Ruidi Biotechnology, Ltd.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in General, Plastic Surgery

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.